CD4+ T cell-mediated killing of major histocompatibility complex class II-positive antigen-presenting cells (APC). III. CD4+ cytotoxic T cells induce apoptosis of APC
- PMID: 1346113
- DOI: 10.1002/eji.1830220139
CD4+ T cell-mediated killing of major histocompatibility complex class II-positive antigen-presenting cells (APC). III. CD4+ cytotoxic T cells induce apoptosis of APC
Abstract
A subset of CD4+ T cells, belonging to the T helper type 1 (Th1) cells, kills antigen-presenting cells (APC) in an antigen-specific and major histocompatibility (MHC) class II-restricted way. Evidence is presented that CD4+ cytotoxic T lymphocytes (CTL) induce apoptosis or programmed cell death within susceptible APC as witnessed by quantitative DNA fragmentation. Apoptosis is more reliable to determine cell death than the 51Cr-release assay, because some cells demonstrate resistance to CD4-mediated lysis in the 51Cr-release assay. Apoptosis becomes manifest after 2 to 4 h of incubation preceding the disintegration of the target cells which is detectable between 12 and 24 h as measured by the 51Cr-release assay. Unstimulated B cells, which are not killed, but function as APC, do not undergo apoptosis, whereas lipopolysaccharide or anti-mu-activated B cell blasts show apoptosis and are efficiently lysed. Several CD4+ Th2-type cells tested, which did not demonstrate killing of APC as measured by the 51Cr-release assay, are unable to mediate programmed cell death of appropriate APC. Actinomycin D or cycloheximide, inhibitors of transcription and translation, respectively, fail to prevent apoptosis of APC excluding the involvement of newly synthesized soluble products as mediators of killing. Pretreatment of CD4+ CTL, but not of APC with 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid, a specific inhibitor of the anion transport, efficiently prevents apoptosis of APC, although the secretion of interleukins is not affected. We propose, that upon contact of the CD4+ CTL with APC, molecules of yet undefined nature are activated and released in a polar fashion at the contact site and induce the endogenous pathway of programmed cell death.
Similar articles
-
CD4+ T cell-mediated killing of MHC class II-positive antigen-presenting cells. I. Characterization of target cell recognition by in vivo or in vitro activated CD4+ killer T cells.J Immunol. 1990 Feb 1;144(3):790-5. J Immunol. 1990. PMID: 1967273
-
Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity.J Immunol. 1994 Feb 1;152(3):1127-33. J Immunol. 1994. PMID: 7507960
-
Requirement for efficient interactions between CD4 and MHC class II molecules for survival of resting CD4+ T lymphocytes in vivo and for activation-induced cell death.J Immunol. 1999 May 15;162(10):5973-80. J Immunol. 1999. PMID: 10229835
-
Measurement of CTL-induced cytotoxicity: the caspase 3 assay.Apoptosis. 2003 Dec;8(6):563-71. doi: 10.1023/A:1026123223387. Apoptosis. 2003. PMID: 14574062 Review.
-
Requirements of exogenous protein antigens for presentation to CD4+ T lymphocytes by MHC class II-positive APC.Adv Exp Med Biol. 1993;329:23-7. doi: 10.1007/978-1-4615-2930-9_4. Adv Exp Med Biol. 1993. PMID: 8104374 Review. No abstract available.
Cited by
-
Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis (programmed cell death).EMBO J. 1993 Jan;12(1):371-7. doi: 10.1002/j.1460-2075.1993.tb05666.x. EMBO J. 1993. PMID: 8428592 Free PMC article.
-
Studies of the mechanism of cytolysis by tumour-infiltrating lymphocytes.Clin Exp Immunol. 1999 Jun;116(3):388-94. doi: 10.1046/j.1365-2249.1999.00879.x. Clin Exp Immunol. 1999. PMID: 10361224 Free PMC article.
-
Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.Immunology. 2005 Aug;115(4):451-61. doi: 10.1111/j.1365-2567.2005.02179.x. Immunology. 2005. PMID: 16011514 Free PMC article.
-
Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line.Diabetologia. 1993 Aug;36(8):716-21. doi: 10.1007/BF00401141. Diabetologia. 1993. PMID: 8405738
-
Adoptive Transfer of Tracer-Alloreactive CD4+ T Cell Receptor Transgenic T Cells Alters the Endogenous Immune Response to an Allograft.Am J Transplant. 2016 Oct;16(10):2842-2853. doi: 10.1111/ajt.13821. Epub 2016 May 13. Am J Transplant. 2016. PMID: 27063351 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials